CME Group Inc. (Chicago Mercantile Exchange, Chicago Board of Trade, New York Mercantile Exchange, The Commodity Exchange) is an American global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, stock indexes and cryptocurrencies futures.
| Revenue (TTM) | $6.76B |
| Gross Profit (TTM) | $6.76B |
| EBITDA | $4.77B |
| Operating Margin | 65.00% |
| Return on Equity | 15.80% |
| Return on Assets | 1.48% |
| Revenue/Share (TTM) | $18.78 |
| Book Value | $73.82 |
| Price-to-Book | 3.67 |
| Price-to-Sales (TTM) | 15.64 |
| EV/Revenue | 14.55 |
| EV/EBITDA | 16.15 |
| Quarterly Earnings Growth (YoY) | 2.50% |
| Quarterly Revenue Growth (YoY) | 0.80% |
| Shares Outstanding | $359.58M |
| Float | $354.65M |
| % Insiders | 0.44% |
| % Institutions | 91.84% |
Volatility is currently contracting
Get a deeper insight into the potential performance of CME (CME) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
I recommend a three-part income strategy: WRB.PR.E baby bond, PSA.PR.H preferred, and CME Group for a blend of yield and growth. WRB.PR.E and PSA.PR.H offers 7%+ yields, trades at discounts, and provides strong credit quality but lacks income growth and inflation protection. CME delivers a 4%+ yield, 8–10% expected EPS growth, and benefits from volatility, offering inflation protection and capital appreciation potential.
Zacks Securities and Exchanges industry players like SPGI, CME, ICE, NDAQ and CBOE gain from rising crypto adoption, a higher non-trading revenue base and tech investments. However, competition remains a drag.
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CME can sustain strong trading volumes through product diversification, global demand and new derivatives offerings, despite moderating volatility.
I surveyed investors on current buys, revealing a focus on quality compounders, exchanges, hard assets, defense, and special situations—no meme stocks appeared. Key opportunities include exchange operators (ICE, CME, and MIAX), with ICE offering nearly a 6% free cash flow yield and trading below its historical average multiple. Cyclical value and defensive names like ODFL, UNP, and NOC remain attractive due to secular tailwinds and compelling valuations, despite recent macro headwinds.
CME Group (CME) continues to deliver robust operating and financial results, with strong trading volumes, recurring revenue, and resilient margins. CME trades at a premium valuation (forward P/E 22.04x), limiting near-term upside unless volatility or global risk-transfer activity increases meaningfully. Recurring market data revenue, new product launches, and global ADV growth reinforce CME's durable business model, but consensus expectations are already high.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Investors watching Europe for discounted stocks relative to the United States or for the impact of ongoing turmoil in the energy sector may miss a critical problem: France's national debt is climbing to 120% of its GDP. Further, the country continues to run deficits well beyond the 3% limit set by the EU, and its 10-year sovereign bond yield recently reached an 18-year high.
Late on Friday, October 2, CME Group (NASDAQ:CME | CME Price Prediction) put out a short release with a direct title: “CME Group Suspends Plans to Launch 24/7 10-Barrel Crude Oil Contract.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CME and any ticker you trade — then tracks every position and per-strategy win rate.
